PMID- 18620796 OWN - NLM STAT- MEDLINE DCOM- 20081203 LR - 20081016 IS - 0301-472X (Print) IS - 0301-472X (Linking) VI - 36 IP - 10 DP - 2008 Oct TI - Regulation of alloimmune responses by dendritic cell subsets. PG - 1309-17 LID - 10.1016/j.exphem.2008.04.021 [doi] AB - OBJECTIVE: Dendritic cells (DCs) are powerful mediators of immune responses. We have demonstrated that the content of plasmacytoid (type 2) dendritic cells (DC2) within allogeneic bone marrow grafts impacts survival and graft-vs-host disease following transplantation. In order to better understand the effect of DC subsets on regulation of immunity, we tested the effect of DC subsets on T cells in a model of indirect antigen presentation to mimic presentation of host-type alloantigen by donor-type DC. MATERIALS AND METHODS: Volunteers underwent apheresis without cytokine priming, and DC1, DC2, naive, and memory T cells were purified by immunomagnetic bead and fluorescein-activated cell sorting. Purified DC1 and DC2 cells were cultured with third-party irradiated blood mononuclear cells and either naive or memory homologous T cells in mixed lymphocyte reactions. RESULTS: Myeloid (type 1) dendritic cells (DC1) induced significant proliferation of homologous T cells and were more effective in priming naive T-cell responses than memory T cells responding to alloantigen. DC2 cells induced minimal T-cell proliferation regardless of the T-cell subset used as the responding fraction. Secondary mixed lymphocyte reaction studies demonstrated that DC2 primed T cells remained hyporesponsive even when challenged with a third-party alloantigen. The immunostimulatory effect of DC1 required DC-to-T-cell contact, and induced interleukin-12 secretion, while DC2 cells induced interferon-gamma secretion. Polymerase chain reaction analysis of DC2-primed T cells demonstrated a significant increase in Foxp3 expression, supporting induction of a regulatory T-cell population. CONCLUSION: DC1 and DC2 cells induced divergent T-cell responses using homologous cells. Better understanding of DC2-mediated T-cell suppression may yield strategies that overcome tumor-specific immune tolerance and regulate graft-vs-host disease. FAU - Lonial, Sagar AU - Lonial S AD - Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA. sloni01@emory.edu FAU - Torre, Claire AU - Torre C FAU - David, Ebenezer AU - David E FAU - Harris, Wayne AU - Harris W FAU - Arellano, Martha AU - Arellano M FAU - Waller, Edmund K AU - Waller EK LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080711 PL - Netherlands TA - Exp Hematol JT - Experimental hematology JID - 0402313 RN - 0 (Antigens, CD) RN - 0 (Cytokines) RN - 0 (FOXP3 protein, human) RN - 0 (Forkhead Transcription Factors) SB - IM MH - Antigens, CD/analysis/immunology MH - Cell Division MH - Cell Separation MH - Cytokines/analysis/immunology MH - Dendritic Cells/cytology/drug effects/*immunology MH - Enzyme-Linked Immunosorbent Assay MH - Flow Cytometry MH - Forkhead Transcription Factors/analysis/genetics MH - Humans MH - Immunologic Memory MH - Lymphocyte Activation MH - Reverse Transcriptase Polymerase Chain Reaction MH - T-Lymphocytes/cytology/immunology EDAT- 2008/07/16 09:00 MHDA- 2008/12/17 09:00 CRDT- 2008/07/16 09:00 PHST- 2006/12/18 00:00 [received] PHST- 2008/04/01 00:00 [revised] PHST- 2008/04/30 00:00 [accepted] PHST- 2008/07/16 09:00 [pubmed] PHST- 2008/12/17 09:00 [medline] PHST- 2008/07/16 09:00 [entrez] AID - S0301-472X(08)00210-5 [pii] AID - 10.1016/j.exphem.2008.04.021 [doi] PST - ppublish SO - Exp Hematol. 2008 Oct;36(10):1309-17. doi: 10.1016/j.exphem.2008.04.021. Epub 2008 Jul 11.